Latest Industry Insights

We spoke to Ari Goldfarb, CEO of Kando, about how their wastewater monitoring technology works and how it is being applied to the current monitoring efforts in the COVID-19 pandemic.

Earlier this year, researchers reported in Annals of Oncology that they had developed a blood test that was able to detect, with 99.3% specificity, more than 50 types of cancer and identify exactly where in the body the cancer had originated – in some cases before any symptoms of the disease had manifested. We spoke to the study’s corresponding author, Michael V. Seiden MD PhD, to learn more.

To discover how the strength of a person’s immune response to SARS-CoV-2 can be assessed, and why this is important, Technology Networks spoke with Andrew Makin, VP Medical Affairs, Oxford Immunotec.

Technology Networks spoke with Rohan Thakur, Executive Vice President of Life Sciences Mass Spectrometry at Bruker Daltonics, to discuss the company's latest analytical technologies and their capabilities.

The Innovative Genomics Institute (IGI) has launched an impressive COVID-19 diagnostic testing laboratory at UC Berkeley. Technology Networks spoke with Professor Jennifer Doudna, Executive Director at IGI and Professor of Molecular and Cell Biology and Chemistry at the University of California, Berkeley, to learn exactly how this ambitious effort has been achieved.

The study of proteins, lipids, metabolites and other related molecules are invaluable in early disease detection and biotherapeutic development. An innovative separation technology borne out of a US Federal Laboratory, known as structures for lossless ion manipulation, is helping scientists to achieving this.

To learn how clinical metagenomics can be used as a tool to diagnose and understand pathogens such as SARS-CoV-2, Technology Networks recently spoke with Robert Schlaberg, co-founder and CMO of IDbyDNA.

To learn more about the impact the COVID-19 pandemic is having on pathology, what the future of pathology might look like, and how digital pathology could help to ease some of the challenges, we spoke to Mark Lloyd, Founder and Executive Vice President of Inspirata.

With advances in cellular and tissue-based imaging, researchers are able to peel back the layers on new challenges and test hypotheses to solve more problems. We heard about some of the advancements being made in the field of confocal microscopy.

Beckman Coulter has recently expanded their range of tools for anemia diagnosis, with the launch of the Access Active-B12 Assay. We spoke to Heather Read-Harper, European Senior Manager for Immunoassay and Clinical Chemistry at Beckman Coulter, to learn more about the assay and the advantages of detecting Active-B12.